← BACK TO SECTORS

Novel Lipid Libraries and LNPs For Targeted Delivery

PENN TECHNOLOGIES

Modified Lipid Nanoparticle Formulations with Improved Therapeutic Delivery to the Bone Microenvironment In-vivo
Ligand-Tethered Lipid Nanoparticles for Targeted RNA Delivery to Treat Liver Fibrosis

PENN STARTUPS

Penn Researchers

Lulu Xue

Michael Mitchell

Xuexiang Han

Keywords

Nanotechnology, Regenerative Medicine, Drug Delivery, Bioengineering, Immunology, Immunoncology, Genetic Disorders, Platform Technology, Gene Therapy, Orthopedics